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GYNECOLOGY

Postpartum contraceptive use among women
with a recent preterm birth
Cheryl L. Robbins, PhD; Sherry L. Farr, PhD; Lauren B. Zapata, PhD;
Denise V. D’Angelo, MPH; William M. Callaghan, MD, MPH
OBJECTIVE: The objective of the study was to evaluate the associa-

tions between postpartum contraception and having a recent preterm
birth.
STUDY DESIGN: Population-based data from the Pregnancy Risk
Assessment Monitoring System in 9 states were used to estimate the
postpartum use of highly or moderately effective contraception (sterilization, intrauterine device, implants, shots, pills, patch, and ring) and
user-independent contraception (sterilization, implants, and intrauterine device) among women with recent live births (2009e2011).
We assessed the differences in contraception by gestational age
(27, 28e33, or 34e36 weeks vs term [37 weeks]) and modeled
the associations using multivariable logistic regression with weighted
data.
RESULTS: A higher percentage of women with recent extreme preterm

birth (27 weeks) reported using no postpartum method (31%)
compared with all other women (15e16%). Women delivering
extreme preterm infants had a decreased odds of using highly or

moderately effective methods (adjusted odds ratio, 0.5; 95% confidence interval, 0.4e0.6) and user-independent methods (adjusted
odds ratio, 0.5; 95% confidence interval, 0.4e0.7) compared with
women having term births. Wanting to get pregnant was more
frequently reported as a reason for contraceptive nonuse by women
with an extreme preterm birth overall (45%) compared with all other
women (15e18%, P < .0001). Infant death occurred in 41% of
extreme preterm births and more than half of these mothers (54%)
reported wanting to become pregnant as the reason for contraceptive
nonuse.
CONCLUSION: During contraceptive counseling with women who had
recent preterm births, providers should address an optimal pregnancy
interval and consider that women with recent extreme preterm birth,
particularly those whose infants died, may not use contraception
because they want to get pregnant.
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I

n 2012, 12% of all US births were
preterm (PTB; <37 weeks’ gestation),1 and preterm-related deaths are
the leading cause of infant mortality.2,3
Short interpregnancy intervals (IPI)
(ie, conception within 18 months of a
previous birth) are associated with
approximately 40% increased risk of
PTB (<37 weeks’ gestation), low birthweight, and small for gestational age4
and an increased risk of recurrent PTB.5

Short IPI has also been linked to severe maternal complications such as
premature membrane rupture, abruption placentae, and placenta previa.6
Consequently, a Healthy People objective aims to reduce the proportion of
pregnancies with short IPI by 10% by
2020 (baseline, 33.1%, 2006e2010).7
Use of highly effective contraception postpartum, particularly userindependent methods, is an important
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strategy for reducing PTB, short IPI, and
recurrent PTB. User-independent methods include male and female sterilization
for those not desiring another pregnancy
and long-acting reversible contraceptives
(LARCs) for women who are not ready
for child-bearing but want to preserve
their fertility.8,9
The American College of Obstetricians and Gynecologists encourages clinicians to offer LARCs as ﬁrst-line
contraception because they are reversible, have very high effectiveness and
continuation rates (>99% of women
avoid an unintended pregnancy within
the ﬁrst year of use), and are cost effective, even when used short term (12e24
months).8,10,11 Permanent contraceptive
methods (sterilization) are also highly
effective (>99%), whereas effectiveness
rates of other moderately effective, userdependent methods (ie, pills, patch,
ring, and shots) range from 91% to 94%
with typical use.10
This document is a U.S. government work and
is not subject to copyright in the United States.
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TABLE 1

Maternal characteristics among sample of postpartum (2e9 mo), nonpregnant, women by history of recent preterm birtha

Maternal characteristics

Recent term birth

Recent preterm birth

‡37 wks (n [ 25,946)

34e36 wks (n [ 3987)

28e33 wks (n [ 1872)

£27 wks (n [ 606)

Weighted, %

95% CI

Weighted, %

Weighted, %

Weighted, %

91.3

90.9e91.6

6.46

95% CI
6.1e6.8

1.72

95% CI
1.6e1.8

0.56

95% CI
0.5e0.6

Age, y
19

.0330
8.4

7.9e8.9

8.3

6.8e10.1

10.1

8.3e12.4

7.9

5.5e11.2

20e24

23.5

22.8e24.3

23.0

20.7e25.5

23.6

20.8e26.7

30.4

24.9e36.6

25e29

31.5

30.6e32.3

29.8

27.2e32.6

26.5

23.5e29.7

24.9

20.5e29.9

30e34

24.3

23.5e25.1

24.5

22.1e27.1

23.9

20.8e27.4

26.1

21.1e31.8

35

12.3

11.8e12.9

14.3

12.4e16.3

15.8

13.7e18.3

10.8

8.1e14.2
< .0001

Race/ethnicity
White, non-Hispanic

72.6

72.0e73.3

71.5

69.1e73.7

63.8

60.3e67.2

57.4

51.5e63.1

Black, non-Hispanic

9.8

9.5e10.2

14.1

12.5e15.9

19.6

17.1e22.4

27.6

22.3e33.5

Other, non-Hispanic

5.6

5.2e6.0

5.0

4.0e6.2

6.9

4.5e10.3

4.9

3.4e7.1

12.0

11.5e12.5

9.5

8.2e10.9

9.7

8.3e11.4

10.1

7.7e13.2

Less than 12th grade

14.4

13.8e15.1

16.3

14.2e18.7

16.7

14.4e19.4

16.4

11.7e22.4

12th grade, GED, or
high school graduate

24.6

23.8e25.4

27.2

24.6e29.9

29.3

26.3e32.5

35.7

30.1e41.7

Some college or more

61.0

60.1e61.9

56.5

53.6e59.3

54.0

50.5e57.5

48.0

42.2e53.8

Hispanic

P value (c2)

.0001

< .0001

Household income, dollars
<10,000

20.3

19.6e21.1

24.8

22.3e27.4

29.3

26.2e32.6

29.9

24.3e36.1

10,000e19,999

15.8

15.1e16.5

16.0

13.9e18.3

16.2

13.3e19.7

20.6

16.4e25.6

20,000e34,999

17.3

16.7e18.1

15.3

13.4e17.4

16.8

14.6e19.4

18.9

14.7e23.9

35,000e49,999

11.5

10.9e12.1

10.0

8.6e11.7

9.3

7.7e11.2

8.1

5.8e11.0

50,000

35.1

34.3e36.0

34.0

31.3e36.7

28.4

25.4e31.5

22.6

18.4e27.5

Gynecology

< .0001

Marital status
Not married

34.1

33.3e35.0

38.7

35.9e41.6

43.6

40.1e47.3

53.6

47.8e59.3

Married

65.9

65.0e66.7

61.3

58.4e64.1

56.4

52.8e59.9

46.4

40.7e52.2
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Education, highest level

Maternal characteristics among sample of postpartum (2e9 mo), nonpregnant, women by history of recent preterm birtha (continued)

Maternal characteristics

Recent term birth

Recent preterm birth

‡37 wks (n [ 25,946)

34e36 wks (n [ 3987)

28e33 wks (n [ 1872)

£27 wks (n [ 606)

Weighted, %

Weighted, %

Weighted, %

Weighted, %

95% CI

95% CI

95% CI

95% CI

.0001

Uninsured

1.8

1.5e2.1

2.0

1.4e2.9

2.0

1.2e3.3

3.2

1.8e5.8

Medicaid

42.8

41.9e43.7

43.5

40.6e46.3

49.8

46.3e53.3

53.1

47.2e53.8

b

8.2

7.7e8.7

10.3

8.5e12.4

9.0

7.3e10.9

9.5

7.1e12.8

Private

47.3

46.4e48.2

44.3

41.4e47.1

39.3

36.0e42.7

34.2

29.1e39.7

Other

< .0001

Prenatal care
None

0.4

0.3e0.5

1.6

1.0e2.5

2.8

1.9e4.2

3.9

1.9e7.9

Late

17.1

16.5e17.9

13.4

11.8e15.2

17.5

15.0e20.4

17.8

13.5e23.1

Early

82.4

81.7e83.1

85.0

83.1e86.7

79.7

76.7e82.4

78.3

72.7e83.1

Yes

18.9

18.1e19.6

24.7

22.1e27.5

23.0

20.2e26.1

23.6

18.9e29.1

No

81.2

80.4e81.9

75.3

72.5e77.9

77.0

73.9e79.8

76.4

70.9e81.2

< .0001

Current smoker

Previous live births, n

.0001

0

39.4

38.5e40.3

38.3

35.5e41.1

43.4

40.0e46.9

41.2

35.7e46.9

1e2

49.7

48.8e50.6

47.4

44.5e50.3

41.8

38.3e45.4

43.3

37.7e49.2

10.9

10.3e11.5

14.3

12.4e16.5

14.8

12.6e17.3

15.5

10.8e21.8

3
Previous preterm birth

Gynecology

Health insurance at delivery

P value (c2)
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TABLE 1

< .0001

c

Yes

4.0

3.5e4.6

14.2

11.0e18.1

17.8

12.5e24.8

13.6

9.4e19.3

No

96.0

95.4e96.5

85.8

81.9e89.0

82.2

75.2e87.5

86.4

80.8e90.6

Yes

0.1

0.1e0.2

0.3

0.1e0.5

2.0

1.3e4.6

40.7

34.7e47.1

No

99.9

99.8e99.9

99.7

99.5e99.9

98.0

95.4e98.7

59.3

52.9e63.4

< .0001

Recent live-born baby died

CI, confidence interval; GED, general education degree.
a

Based on Pregnancy Risk Assessment Monitoring System, 9 US states, 2009e2011 (n ¼ 32,411); b Includes Tri-Care, other military, Indian Health Services, state-specific Children’s Health Insurance Plan, Children’s Health Insurance Plan; c Among multiparous
women only (n ¼ 14,068).
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Although several studies have examined contraceptive methods used postpartum,12-15 none have focused on
women with a recent PTB, a group that is
at risk of future PTB and in need of
highly effective contraception to prevent
short IPI and reduce recurrent PTB. We
examined the prevalence of postpartum
contraceptive use among women with
recent live births and explored the associations between recent PTB and the
consequent use of highly and moderately
effective methods. We also investigated
whether associations vary by insurance
type and examined the reasons for contraceptive nonuse.

M ATERIALS

AND

M ETHODS

This analysis is based on data from
the Pregnancy Risk Assessment Monitoring System (PRAMS), an ongoing
population-based survey of women with
live births in the past 2e9 months. The
PRAMS research design and survey
methods have been described elsewhere,16 and additional details are
available from the PRAMS web site
(http://www.cdc.gov/prams).
Brieﬂy, each participating state draws
a stratiﬁed random sample from birth
certiﬁcates and mails up to 3 surveys to
each selected participant. Women who
do not respond to the mailings are followed up by telephone. The data are
weighted to account for sampling frame,
noncoverage, and participant nonresponse, thus allowing for populationbased inferences. The PRAMS protocol
was approved by the Centers for Disease
Control and Prevention’s Institutional
Review Board, and participating states
approved the study analysis plan.

Data
PRAMS surveys comprise core questions
that are asked by all participating sites
and standard optional questions that
sites may choose to add. For this analysis,
we analyzed 2009e2011 data from 9
states (Arkansas, Colorado, Michigan,
Nebraska, Ohio, Oregon, Rhode Island,
Tennessee, and Utah) that asked the
optional question about speciﬁc contraceptive methods used postpartum and
achieved an overall weighted response
rate of 65% or greater.

Measures
We estimated gestational age using the
clinical estimate reported on the birth
certiﬁcate and categorized gestational
age as term births (37 weeks) and PTB
(34e36 weeks, 28e33 weeks, and 27
weeks [extreme PTB]). The gestational
age categories were selected a priori.
To describe postpartum contraceptive
use, we examined responses to the
following questions: “Are you or your
husband or partner doing anything now
to keep from getting pregnant?” and
“What kind of birth control are you or
your husband or partner using now to
keep from getting pregnant?” Because
respondents could report multiple
methods, the most effective method of
all responses was selected.10
Contraceptive use was categorized
according to effectiveness.10
 Highly and moderately effective
methods were those with which fewer
than 10% of women have an unintended pregnancy within the ﬁrst year
of use: permanent methods (tubal
ligation or vasectomy) and LARCs
(intrauterine device or contraceptive
implant) and moderately effective
user-dependent methods (shots, pill,
patch, and ring).
 Less effective methods were those
with which 10% or more of women
have an unintended pregnancy within
the ﬁrst year of use: male and female
condoms, diaphragm, cervical cap,
sponge, emergency contraception,
rhythm, withdrawal, and other.
 No contraceptive method (nonuse)
was coded when women answered no
to current contraceptive use or reported that their only method was
abstinence.
All nonusers were asked about reasons
for not using contraceptives, speciﬁcally,
“What are your reasons or your husband’s or partner’s reasons for not doing
anything to keep from getting pregnant
now?” Multiple close-ended responses
were allowed and included the following
responses: “I am not having sex,” “I want
to get pregnant,” “I don’t want to use
contraception,” “My husband or partner
doesn’t want to use anything,” “I don’t

Research

think I can get pregnant,” “I can’t pay for
birth control,” and “other reason.” Respondents also had the option to write in
a response.

Analysis
Of 37,089 respondents, 4678 (12.6%)
were excluded because of a current
pregnancy or hysterectomy (0.6%) or
missing information on postpartum
contraceptive method (2.8%) or covariates (9.2%). Women who reported
abstinence were included in our analysis
as nonusers because 90% of postpartum
women resume sexual activity by 4
months postpartum17 and hence are at
risk for pregnancy.
Our ﬁnal analytical sample included
32,411 nonpregnant women with recent
live births and data on all covariates. We
estimated the prevalence of maternal
characteristics and postpartum contraceptive use (highly or moderately effective methods, less effective methods, and
no method) stratiﬁed by PTB group and
used c2 tests to assess the statistical differences (P < .05).
Using a multivariable logistic regression to control for potential confounders, we evaluated the associations
between recent PTB and 2 measures of
postpartum contraceptive use: (1) any
highly or moderately effective contraceptive method (vs less effective methods
and no method) and (2) highly effective
user-independent methods (vs moderately effective methods, less effective
methods, and no method). Potential
confounders identiﬁed from the literature were age, race/ethnicity, education,
income, health insurance, marital status,
prenatal care, parity, and smoking.
We conducted sensitivity analyses of
the multivariable models among subgroups of women who expressed no
concerns about potential infertility (n ¼
32,309) and multiparous women, additionally controlling for pregnancy
intention and previous PTB (n ¼
14,068). We also examined associations
between infant death and contraceptive
use among women who had extreme
PTB (n ¼ 517).
We assessed effect modiﬁcation by
insurance type at delivery (private,
Medicaid, other, none) for the full
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sample by examining statistical signiﬁcance of interaction terms between PTB
and insurance type for both outcomes (P
< .05). All analyses were conducted using weighted data and STATA 13 (2013;
StataCorp LP, College Station, TX) to
adjust for the complex survey design,
thus allowing for population inferences.

FIGURE

Percentage of postpartum contraceptive method type

R ESULTS
A larger percentage of excluded women
had recent PTB (10.4%) compared with
the analytical sample (8.7%; P ¼ .005)
and reported no postpartum contraceptive method (24.4% vs 8.7%; P <.0001).
Of excluded women, recent PTB was
even higher among the subset of
excluded pregnant women (14.1%).
Excluded women were also more likely
to be young, minority race/ethnicity, low
income, and unmarried and reported
late entry into prenatal care and less
likely to be college educated or privately
insured.
Prevalence of having a recent PTB was
8.7%, of which extreme PTB accounted
for less than 1% (Table 1). Compared
with women who had recent term births,
a higher percentage of women with
recent PTBs were non-Hispanic black,
low income, unmarried, and current
cigarette smokers. Additionally, a higher
percentage of women with recent PTBs
reported having had 3 or more previous
live births, previous PTB, no prenatal
care for the most recent live birth, and
death of the most recent live-born infant.
A smaller percentage of women with
recent PTB were college educated or had
private insurance (compared with
women with recent term births). Infant
death varied by gestational age of the
recent birth: 41% at 27 weeks or less, 2%
at 28e33 weeks, and less than 1% for 34
weeks or longer.
Postpartum contraceptive use varied
by gestational age of the most recent
birth (Figure, P < .0001). Nearly half of
all women with a recent PTB (39%) reported using a less effective method or
no method at all. Except for those with a
recent extreme preterm birth, most
women reported using moderately
effective user-dependent methods.
Women with extreme PTB most
frequently reported no method (31%),

This figure depicts the prevalence of postpartum contraception use (permanent, LARCs, highly and
moderately effective user-dependent methods, less effective methods, none) stratified by the most
recent birth outcome (term or preterm: 34e36 weeks, 28e33 weeks, 27 weeks).
LARC, long-acting reversible contraceptive.
Robbins. Postpartum contraceptive use and preterm birth. Am J Obstet Gynecol 2015.

at approximately twice the prevalence
that was reported by all other groups of
women (15e16%).
Women with extreme PTB also had
the lowest prevalence of using moderately effective user-dependent methods
(25%), LARCs (10%), and permanent
contraception (8%), compared with all
other groups of women. In subgroup
analyses among women with an extreme
PTB, a higher percentage of women
whose infants died used no method
(42%) compared with their counterparts
whose infants survived (19%, P ¼ .0003;
not shown).
After adjusting for confounders,
women with extreme PTB had half the
odds (adjusted odds ratio, 0.5) of using
any highly or moderately effective
method or user-independent methods,
compared with women who had recent
term births (Table 2). However, point
estimates for other women with PTB

508.e5 American Journal of Obstetrics & Gynecology OCTOBER 2015

(28e33 and 34e36 weeks) did not statistically differ from those with term
births. The point estimates for using any
highly or moderately effective method,
or user-independent methods among
women with extreme PTB were unchanged in sensitivity analyses for the
subsample of women who expressed no
concerns about potential infertility or
after controlling for previous PTB and
pregnancy intention for the subsample
of multiparous women (not shown). We
found no evidence of effect modiﬁcation
by insurance type.
Among women with extreme PTB, the
most frequently reported reason for
contraceptive nonuse was the desire to
get pregnant (45%), and this reason was
more prevalent when limited to those
with an extreme PTB who lost their infants (54%, data not shown). Among
women who were not using any contraception, lower percentages of women

ajog.org
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TABLE 2

aORs and 95% CIs modeling associations between postpartum contraceptive methods and history of recent
preterm birtha
Postpartum use of contraception
Highly effective user-independent
contraceptive methodsc

Highly or moderately effective
contraceptive methodsb
Most recent live birth,
wks of gestation

aORd

37

Reference

34e36

1.1

1.0e1.3

1.1

0.9e1.2

28e33

1.1

1.0e1.3

1.2

1.0e1.4

27

0.5

0.4e0.6

0.5

0.4e0.7

95% CI

aOR

95% CI

Reference

aOR, adjusted odds ratio; CI, confidence interval.
a

Based on Pregnancy Risk Assessment Monitoring System, 9 US states, 2009e2011 (n ¼ 32,411); b Includes tubal ligation, vasectomy, intrauterine devices, implants, shots, pill, patch, and ring
(vs male and female condoms, diaphragm, cervical cap, sponge, emergency contraception, rhythm, withdrawal, other, and no method); c Includes tubal ligation, vasectomy, intrauterine devices, or
implants (vs shots, pill, patch, and ring, male and female condoms, diaphragm, cervical cap, sponge, emergency contraception, rhythm, withdrawal, other, and no method); d Adjusted for age,
race/ethnicity, education, income, insurance, marital status, prenatal care entry, parity, and smoking.

Robbins. Postpartum contraceptive use and preterm birth. Am J Obstet Gynecol 2015.

with recent PTB at 28e33 weeks and 27
weeks or less reported not wanting to use
contraception (21% and 17%, respectively) than women who had term births
(35%, Table 3).
Many women with a recent term birth
(29%) or PTB (17e28%) alike reported
reasons for contraception nonuse other
than those in the explicit response options. Believing that one could not get
pregnant, current breast-feeding, and
pregnancy ambivalence or desire were
the most frequent reasons noted among
women who reported other response.
Financial barriers to obtaining birth
control were infrequently reported as a
reason by all groups (6e11%).

C OMMENT
Overall, nearly half of all women with
recent PTB reported using less effective
contraceptive methods or no method.
Women with a recent extreme PTB had a
reduced odds of using any highly or
moderately effective method or userindependent methods, compared with
women with recent term births. We also
found that a higher percentage of
women with extreme PTB whose infants
died used no method (42%) compared
with their counterparts whose infants
survived (19%). This ﬁnding suggests
that the observed associations between

extreme PTB and contraceptive effectiveness are mediated by infant death.
The associations between the gestational age of the recent birth and the use
of any highly or moderately effective
method did not differ according to insurance status. Reasons for not using
contraception differed by a recent history of PTB. Of women whose recent
extreme PTB resulted in infant death,
more than half reported not using
contraception because they wanted to
become pregnant. Wanting to get pregnant was more frequently reported
among women with a recent extreme
PTB than among women who had term
births. Financial barriers were infrequently reported for contraceptive
nonuse among all women.
PTB is a strong predictor of recurrent
PTB,18 and our ﬁnding that approximately half of women with recent PTB
were using less effective methods or no
contraception should serve as a call to
action. Many women with a recent PTB,
particularly those whose babies died,
want to get pregnant and therefore do
not use contraception postpartum. Providers need to consider this possibility
during contraceptive counseling.
Contraceptive counseling on the
negative consequences of short IPI
and early postpartum access to highly

effective contraception, such as LARCs
or sterilization, if appropriate and
desired by the woman, is a critical
strategy for reducing short IPI and
PTB.19,20 Providers can also use the
contraceptive counseling moment as an
opportunity to correct misperceptions
about impaired postpartum fertility.
This is important because postpartum
women may underestimate their fertility
after birth.21
The earliest and possibly best opportunity for initiating highly effective
contraception postpartum is before
hospital discharge after delivery. There
are a couple of reasons for this. First,
sexual activity frequently occurs before
the postpartum visit.22 Second, the
postpartum period can be a chaotic time,
and new mothers can be narrowly
focused on their newborns during that
time. This may be particularly true for
women with critically ill infants undergoing intensive care. As a result of this
intense focus on newborns, women may
neglect their own needs during the
postpartum period. For example, a large
study of Medicaid claims in California
found less than half of postpartum
women (41%) received contraceptive
services within the ﬁrst 3 months of
giving birth.23 Although it is ideal to
provide immediate access to highly
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Based on Pregnancy Risk Assessment Monitoring System, 9 US states, 2009e2011 (among 4280 postpartum women who reported no current contraceptive use).
a

CI, confidence interval.
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15.1e28.5
21.0
20.7e36.3
27.8
28.5
Other reason

26.1e31.0

.0003

.4079
3.8e17.8

1.6e12.9
4.6

8.4
6.0e17.7

10.0e21.3
14.8

10.5
4.4e10.4

5.6e12.6
8.5

6.8
6.3

5.1e7.7

5.2
I do not think I can get pregnant (sterile)

I cannot pay for birth control

4.1e6.5

.3544
2.8e17.7
7.3
5.4e18.2
10.1
8.2e16.2
11.6
13.6
My husband or partner does not want to use anything

11.9e15.6

.0022
10.3e26.8
17.0
14.1e28.8
20.5
21.2e36.3
28.1
35.4
I do not want to use contraception

32.9e38.0

.0001
32.4e58.6
45.2
10.9e21.0
15.3
12.6e23.9
17.6
17.7
I want to get pregnant

15.8e19.8

.5716
13.7e34.3
22.4
26.2e41.6
33.5
21.2e34.9
27.5
28.0
I am not having sex

25.8e30.4

95% CI
Weighted, %
Weighted, %
Weighted, %
Reason given

95% CI

34e36 wks
‡37 wks

95% CI

Weighted, %

95% CI

£27 wks
28e33 wks
Recent preterm birth
Recent term birth

Reasons for not using contraception by gestational age of recent birtha

TABLE 3
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P value (c2)
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effective contraception after delivery,
unfortunately, the global fee for deliveryrelated care typically does not include
reimbursement for contraception.24
The postpartum visit provides
another important opportunity for
contraceptive counseling and contraception initiation. Zutshi et al25 recently
investigated risk factors for short IPI
among women who attended an
obstetrics-gynecology residence clinic in
a large community hospital and found
women who received postpartum visits
had lower rates of pregnancy within 18
months of delivery.
Highly effective contraception can be
initiated at the postpartum visit without
waiting for menses to resume if the
clinician is reasonably certain the
woman is not pregnant. This strategy,
known as Quick Start, is recommended
by the Centers for Disease Control and
Prevention26,27 and has been shown to
be safe and effective.28,29 Unfortunately,
nearly one fourth of women who deliver
do not return for postpartum visits.30
For these women, Quick Start of
contraception could be offered at other
medical visits for the mother or her infant during the postpartum period.
The ﬁndings from our study are subject to the following limitations. First,
PRAMS data were not available for all
states; the 9 states in our analysis represent approximately 14% of US births;
white women are overrepresented and
non-Hispanic black and Hispanic
women are underrepresented compared
with the US population.31 Second,
PRAMS surveys only women who
delivered live infants; we cannot
comment on women who had stillbirths
or miscarriages. Third, misclassiﬁcation
is possible because some women use
contraceptive methods other than those
speciﬁed by the survey options. For
example, PRAMS does not assess breastfeeding exclusivity. Therefore, women
relying on lactation amenorrhea may be
misclassiﬁed as nonusers. Fourth, selection bias is possible because nearly 13%
women were excluded, and larger percentages of excluded women had recent
PTB compared with the analytic sample.
Fifth, we did not exclude women who
reported that they were not currently

ajog.org
sexually active because we assumed that
sexual activity would most likely resume,
putting them at risk of short IPI. If
anything, this would lead to underestimates of contraceptive method
types compared with those reported by
other studies that excluded abstinent
women. However, our estimates generally aligned with ranges reported by
other studies.
Despite these limitations, the study
results suggest that women with a recent
PTB may beneﬁt from contraceptive
counseling on the negative consequences
of short IPI. Additionally, contraceptive
providers should consider that women
whose infants died may want to become
pregnant again relatively soon and
address optimal pregnancy intervals
with sensitivity.
Contraceptive counseling that encourages the use of highly effective contraceptive methods and dispels myths
about impaired fertility during the
postpartum period is important for all
postpartum women, especially those
with a recent history of PTB. Patient and
institutional barriers to using highly
effective contraception postpartum need
to be addressed, and research should
explore whether women with recent PTB
encounter additional barriers. Use of
highly effective postpartum contraception may be improved with additional
education about fertility during the
postpartum period and with increased
opportunities to receive contraceptive
counseling at all medical visits for
mothers and their infants during the
postpartum period.
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